Researchers used the Nationwide Inpatient Sample and Census Bureau data to quantify incidence and associated costs of S. aureus-SSTI hospitalizations for the nine year period.
Hospitalizations related to S. aureus-SSTIs rose 123 percent between 2001 and 2009, and they also represented a greater share of all hospitalizations relating to S. aureus, rising from 39 percent in 2001 to 51 percent in 2009.
Total annual costs also increased, peaking in 2008 at $4.84 billion, a 44 percent increase from 2001, according to the study. In 2009, the average cost of a S. aureus-SSTI hospitalization was $11,622.
“Efforts to prevent S. aureus-SSTIs and MRSA-associated SSTIs could have a meaningful impact on healthcare costs for this common infection,” the researchers concluded.
More Articles on Infection Control:
New CMS Guidance Recommends Monitoring of All Patients Receiving Opioids: What It Means for Healthcare Providers
Birmingham VA Medical Center Found Low Levels of Legionella Bacteria
CDC Launches New Sepsis Website
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.